Nihon Kohden to Acquire Majority Stake in NeuroAdvanced for 16 Billion Yen
Nihon Kohden (TYO:6849) is acquiring a majority stake of 71.4% in NeuroAdvanced, the parent company of Ad-Tech Medical Instrument, for about 16 billion yen.
As a result, the medical equipment manufacturer said Ad-Tech will become consolidated and specified subsidiaries of Nihon Kohden, according to its filing on Thursday.
The acquisition involves a stock purchase agreement with NeuroNewCo, a fund which owns 100% shares in NeuroAdvanced, and a shareholders agreement outlining future business operations and potential full acquisition of NeuroAdvanced.
The acquisition is part of Nihon Kohden's long-term vision to solve global medical issues and expand its consumables and services business in North America.
The share transfer is scheduled to take place Nov. 29
Nihon Kohden's shares gained over 2% in early trade.
Price (JPY): $2089.00, Change: $+45, Percent Change: +2.18%
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。